Onkaido Therapeutics
About:
The Onkaido Therapeutics team is exploring how messenger RNA therapeutics™ can deliver novel oncology drugs to help patients.
Website: http://onkaido.com
Top Investors: Moderna
Description:
The Onkaido Therapeutics team is exploring how messenger RNA therapeutics™ can deliver novel oncology drugs to help patients.
Total Funding Amount:
$20M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Cambridge, Massachusetts, United States
Founded Date:
2013-01-01
Contact Email:
info(AT)modernatx.com
Founders:
Stephen Hoge
Number of Employees:
11-50
Last Funding Date:
2014-01-14
IPO Status:
Private
Industries:
© 2025 bioDAO.ai